IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL - ANVISA Registration 80000230085
Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80000230085 and manufactured by manufacturer not specified. The registration is held by AGILENT TECHNOLOGIES BRASIL LTDA with validity until Feb 13, 2033.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including VENTANA MEDICAL SYSTEM, INC, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamRelated Devices (2)
Registration Details
80000230085
25351381889202280
03290250000100
Company Information
Dates and Status
Feb 13, 2023
13/02/2033
09/18/2025 19:00:01
IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL
FAMÍLIA MARCADOR TUMORAL PD-L1
AGILENT TECHNOLOGIES, INC.
80000230077
Apr 03, 2017
IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL
FAMÍLIA MARCADOR TUMORAL PD-L1
Not specified
80000230077
Apr 03, 2017
IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL
VENTANA PD-L1 (SP263) RABBIT MONOCLONAL PRIMARY ANTIBODY
VENTANA MEDICAL SYSTEMS, INC
10287411170
Oct 24, 2016
IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL
VENTANA PD-L1 (SP263) RABBIT MONOCLONAL PRIMARY ANTIBODY
Not specified
10287411170
Oct 24, 2016
IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL
FAMÍLIA DE MARCADORES DE CARCINOMAS EM GERAL
CELL MARQUE CORPORATION
80358430001
Mar 31, 2010
VENTANA MEDICAL SYSTEM, INC• United States of America
ROCHE DIAGNOSTICS GMBH• Germany
AGILENT TECHNOLOGIES, INC.• United States of America
AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.• Singapore
CELL MARQUE CORPORATION• United States of America
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS EM GERAL
INSM1 (SP493) Rabbit Monoclonal Primary Antibody
VENTANA MEDICAL SYSTEM, INC
10287411763
Sep 15, 2025
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS EM GERAL
INSM1 (SP493) Rabbit Monoclonal Primary Antibody
Not specified
10287411763
Sep 15, 2025
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS EM GERAL
CD68 (SP251v18) Rabbit Monoclonal Antibody
VENTANA MEDICAL SYSTEM, INC
10287411757
Sep 01, 2025
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS EM GERAL
CD68 (SP251v18) Rabbit Monoclonal Antibody
Not specified
10287411757
Sep 01, 2025
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS EM GERAL
MARCADOR DE CARCINOMA - MIOGENINA
AGILENT TECHNOLOGIES, INC.
80000230091
Oct 21, 2024